Dystonia in a patient with melanoma metastatic to the brain treated with high-dose interleukin-2, radiation therapy, and levetiracetam

Varun Sreenivasan; Arkadiusz Z. Dudek

doi:10.1159/000346932

Dystonia in a patient with melanoma metastatic to the brain treated with high-dose interleukin-2, radiation therapy, and levetiracetam

Varun Sreenivasan
, Arkadiusz Z. Dudek

Medicine - Hematology, Oncology, Transplant

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

Dystonia has been described as a potential toxicity of radiation therapy. Management of this rare movement disorder is targeted in symptom improvement. We report a case of a 46-year-old female patient who developed dystonia during treatment of melanoma metastatic to the brain and discuss potential causes of and therapies for this rare complication.

Original language	English (US)
Pages (from-to)	78-83
Number of pages	6
Journal	Case Reports in Oncology
Volume	6
Issue number	1
DOIs	https://doi.org/10.1159/000346932
State	Published - Jan 2013

Keywords

Brain metastasis
Dystonia
Gamma Knife therapy
High-dose interleukin-2
Levetiracetam
Melanoma

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.1159/000346932

Find It

Find It at U of M Libraries

Cite this

@article{390dd27723364f0784e9d4bac849c56b,

title = "Dystonia in a patient with melanoma metastatic to the brain treated with high-dose interleukin-2, radiation therapy, and levetiracetam",

abstract = "Dystonia has been described as a potential toxicity of radiation therapy. Management of this rare movement disorder is targeted in symptom improvement. We report a case of a 46-year-old female patient who developed dystonia during treatment of melanoma metastatic to the brain and discuss potential causes of and therapies for this rare complication.",

keywords = "Brain metastasis, Dystonia, Gamma Knife therapy, High-dose interleukin-2, Levetiracetam, Melanoma",

author = "Varun Sreenivasan and Dudek, \{Arkadiusz Z.\}",

year = "2013",

month = jan,

doi = "10.1159/000346932",

language = "English (US)",

volume = "6",

pages = "78--83",

journal = "Case Reports in Oncology",

issn = "1662-6575",

publisher = "S. Karger AG",

number = "1",

}

TY - JOUR

T1 - Dystonia in a patient with melanoma metastatic to the brain treated with high-dose interleukin-2, radiation therapy, and levetiracetam

AU - Sreenivasan, Varun

AU - Dudek, Arkadiusz Z.

PY - 2013/1

Y1 - 2013/1

N2 - Dystonia has been described as a potential toxicity of radiation therapy. Management of this rare movement disorder is targeted in symptom improvement. We report a case of a 46-year-old female patient who developed dystonia during treatment of melanoma metastatic to the brain and discuss potential causes of and therapies for this rare complication.

AB - Dystonia has been described as a potential toxicity of radiation therapy. Management of this rare movement disorder is targeted in symptom improvement. We report a case of a 46-year-old female patient who developed dystonia during treatment of melanoma metastatic to the brain and discuss potential causes of and therapies for this rare complication.

KW - Brain metastasis

KW - Dystonia

KW - Gamma Knife therapy

KW - High-dose interleukin-2

KW - Levetiracetam

KW - Melanoma

UR - https://www.scopus.com/pages/publications/84877939015

UR - https://www.scopus.com/pages/publications/84877939015#tab=citedBy

U2 - 10.1159/000346932

DO - 10.1159/000346932

M3 - Article

C2 - 23467479

AN - SCOPUS:84877939015

SN - 1662-6575

VL - 6

SP - 78

EP - 83

JO - Case Reports in Oncology

JF - Case Reports in Oncology

IS - 1

ER -

Dystonia in a patient with melanoma metastatic to the brain treated with high-dose interleukin-2, radiation therapy, and levetiracetam

Abstract

Keywords

UN SDGs

Publisher link

Find It

Other files and links

Fingerprint

Cite this